JP2013047268A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013047268A5 JP2013047268A5 JP2012252220A JP2012252220A JP2013047268A5 JP 2013047268 A5 JP2013047268 A5 JP 2013047268A5 JP 2012252220 A JP2012252220 A JP 2012252220A JP 2012252220 A JP2012252220 A JP 2012252220A JP 2013047268 A5 JP2013047268 A5 JP 2013047268A5
- Authority
- JP
- Japan
- Prior art keywords
- spp
- use according
- peptide comprises
- amino acids
- arginines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 235000001014 amino acid Nutrition 0.000 claims 8
- 150000001413 amino acids Chemical class 0.000 claims 8
- 235000009697 arginine Nutrition 0.000 claims 7
- 150000001484 arginines Chemical class 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- 239000004472 Lysine Substances 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 229960003104 ornithine Drugs 0.000 claims 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241000589969 Borreliella burgdorferi Species 0.000 claims 1
- 241001453380 Burkholderia Species 0.000 claims 1
- 241000589876 Campylobacter Species 0.000 claims 1
- 241000606161 Chlamydia Species 0.000 claims 1
- 241001112696 Clostridia Species 0.000 claims 1
- 108010069514 Cyclic Peptides Proteins 0.000 claims 1
- 102000001189 Cyclic Peptides Human genes 0.000 claims 1
- 241000588914 Enterobacter Species 0.000 claims 1
- 241000194033 Enterococcus Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241000589602 Francisella tularensis Species 0.000 claims 1
- 241000606790 Haemophilus Species 0.000 claims 1
- 241000589989 Helicobacter Species 0.000 claims 1
- 241000186781 Listeria Species 0.000 claims 1
- 241000186359 Mycobacterium Species 0.000 claims 1
- 241000588653 Neisseria Species 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 241000607768 Shigella Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 241000589886 Treponema Species 0.000 claims 1
- 241000607734 Yersinia <bacteria> Species 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940118764 francisella tularensis Drugs 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0526120.1 | 2005-12-22 | ||
| GBGB0526120.1A GB0526120D0 (en) | 2005-12-22 | 2005-12-22 | Therapeutic peptides |
| US77650506P | 2006-02-24 | 2006-02-24 | |
| US60/776,505 | 2006-02-24 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546630A Division JP5559477B2 (ja) | 2005-12-22 | 2006-12-21 | 環状抗微生物ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013047268A JP2013047268A (ja) | 2013-03-07 |
| JP2013047268A5 true JP2013047268A5 (enExample) | 2013-12-12 |
| JP6050096B2 JP6050096B2 (ja) | 2016-12-21 |
Family
ID=37836928
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546630A Active JP5559477B2 (ja) | 2005-12-22 | 2006-12-21 | 環状抗微生物ペプチド |
| JP2012252220A Expired - Fee Related JP6050096B2 (ja) | 2005-12-22 | 2012-11-16 | 環状抗微生物ペプチド |
| JP2014090998A Expired - Fee Related JP6199797B2 (ja) | 2005-12-22 | 2014-04-25 | 環状抗微生物ペプチド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546630A Active JP5559477B2 (ja) | 2005-12-22 | 2006-12-21 | 環状抗微生物ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014090998A Expired - Fee Related JP6199797B2 (ja) | 2005-12-22 | 2014-04-25 | 環状抗微生物ペプチド |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8324154B2 (enExample) |
| EP (4) | EP2357191A3 (enExample) |
| JP (3) | JP5559477B2 (enExample) |
| KR (1) | KR101413746B1 (enExample) |
| AU (1) | AU2006327973B2 (enExample) |
| CA (1) | CA2655448C (enExample) |
| CY (1) | CY1113770T1 (enExample) |
| IL (2) | IL192373A (enExample) |
| MX (1) | MX2008008291A (enExample) |
| NO (1) | NO346186B1 (enExample) |
| PL (1) | PL1976863T3 (enExample) |
| RU (1) | RU2463308C2 (enExample) |
| WO (1) | WO2007072037A1 (enExample) |
| ZA (1) | ZA200806329B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2655448C (en) * | 2005-12-22 | 2016-09-06 | Novabiotics Limited | Cyclic antimicrobial peptides |
| GB0702020D0 (en) | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
| AU2010203698B2 (en) | 2009-01-06 | 2016-07-21 | C3 Jian, Inc. | Targeted antimicrobial moieties |
| WO2012135846A1 (en) * | 2011-04-01 | 2012-10-04 | Northeastern University | Methods of eradicating bacterial cell populations |
| WO2013096823A1 (en) * | 2011-12-21 | 2013-06-27 | Regents Of The University Of Minnesota | Cationic peptides and use of such peptides for inhibiting exotoxin production |
| KR101502797B1 (ko) * | 2012-08-22 | 2015-03-17 | 연세대학교 산학협력단 | 신규한 양친매성 고리형 펩티드, 이의 제조방법 및 이를 포함하는 안정한 자기조립 나노전달체 |
| US9082888B2 (en) | 2012-10-17 | 2015-07-14 | New York University | Inverted orthogonal spin transfer layer stack |
| DK3149025T3 (da) | 2014-05-21 | 2019-07-22 | Entrada Therapeutics Inc | Cellepenetrerende peptider og fremgangsmåder til frembringelse og anvendelse deraf |
| US10815276B2 (en) | 2014-05-21 | 2020-10-27 | Entrada Therapeutics, Inc. | Cell penetrating peptides and methods of making and using thereof |
| EP3185880B1 (en) | 2014-08-27 | 2020-02-12 | Ohio State Innovation Foundation | Improved peptidyl calcineurin inhibitors |
| EP3903823A3 (en) * | 2015-03-23 | 2022-02-23 | Riptide Bioscience, Inc. | Antimicrobial peptides and methods of use thereof |
| KR101692992B1 (ko) | 2015-05-20 | 2017-01-17 | 연세대학교 산학협력단 | 고리형 펩타이드의 사전 활성화 합성방법 및 이에 따라 합성된 고리형 펩타이드 |
| WO2019070962A1 (en) | 2017-10-04 | 2019-04-11 | Ohio State Innovation Foundation | BICYCLIC PEPTIDE INHIBITORS |
| US11793884B2 (en) | 2018-01-29 | 2023-10-24 | Ohio State Innovation Foundation | Cyclic peptidyl inhibitors of CAL-PDZ binding domain |
| WO2019148194A2 (en) | 2018-01-29 | 2019-08-01 | Ohio State Innovation Foundation | Peptidyl inhibitors of calcineurin-nfat interaction |
| EP3755351A4 (en) | 2018-02-22 | 2021-11-24 | Entrada Therapeutics, Inc. | COMPOSITIONS AND TREATMENT METHODS FOR MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY |
| US11987647B2 (en) | 2018-05-09 | 2024-05-21 | Ohio State Innovation Foundation | Cyclic cell-penetrating peptides with one or more hydrophobic residues |
| GB202010268D0 (en) * | 2020-07-03 | 2020-08-19 | Novabiotics Ltd | Nail formulations and treatment regimes |
| CN115716865B (zh) * | 2022-11-24 | 2024-04-30 | 安徽农业大学 | 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-苏-酪-缬-亮肽及制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4051842A (en) | 1975-09-15 | 1977-10-04 | International Medical Corporation | Electrode and interfacing pad for electrical physiological systems |
| DE2626348C3 (de) | 1976-06-11 | 1980-01-31 | Siemens Ag, 1000 Berlin Und 8000 Muenchen | Implantierbare Dosiereinrichtung |
| US4383529A (en) | 1980-11-03 | 1983-05-17 | Wescor, Inc. | Iontophoretic electrode device, method and gel insert |
| US4962091A (en) | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
| US5652211A (en) * | 1991-02-11 | 1997-07-29 | Biosynth S.R.L. | Peptides for neutralizing the toxicity of Lipid A |
| CA2145093C (en) | 1992-09-25 | 2007-04-10 | Lawrence Leroy Kunz | Therapeutic inhibitor of vascular smooth muscle cells |
| EP0839156A1 (en) * | 1995-07-20 | 1998-05-06 | Xoma Corporation | Anti-fungal peptides |
| DE19534177A1 (de) * | 1995-09-15 | 1997-03-20 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
| US5916872A (en) * | 1996-07-24 | 1999-06-29 | Intrabiotics Pharmaceuticals, Inc. | Cyclic peptides having broad spectrum antimicrobial activity |
| US6096707A (en) * | 1997-07-11 | 2000-08-01 | Biotie Therapies Ltd. | Integrin binding peptide and use thereof |
| US6951652B2 (en) * | 1998-07-29 | 2005-10-04 | Biosynth S.R.L. | Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases |
| JP2004535392A (ja) * | 2001-05-04 | 2004-11-25 | ザ スクリプス リサーチ インスティチュート | 抗菌ペプチドおよび組成物 |
| US7033991B2 (en) * | 2001-07-16 | 2006-04-25 | Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College | Inhibiting furin with polybasic peptides |
| AU2003228896A1 (en) * | 2002-05-06 | 2003-11-17 | The Scripps Research Institute | Anti-microbial peptides and compositions |
| AU2003297657A1 (en) * | 2002-11-29 | 2004-06-23 | Adaptive Therapeutics, Inc. | Antifungal therapeutic agents |
| US6783677B1 (en) * | 2003-02-06 | 2004-08-31 | Mayyar Systems, Inc. | Anaerobic film biogas digester system |
| WO2004110341A2 (en) * | 2003-06-19 | 2004-12-23 | Yeda Research & Development Co. Ltd. | Antimicrobial and anticancer lipopeptides |
| DK1778720T3 (da) * | 2004-08-18 | 2010-11-29 | Novabiotics Ltd | Antimikrobielle peptider omfattende et arginin- og/eller lysinholdigt motiv |
| CA2655448C (en) * | 2005-12-22 | 2016-09-06 | Novabiotics Limited | Cyclic antimicrobial peptides |
-
2006
- 2006-12-21 CA CA2655448A patent/CA2655448C/en active Active
- 2006-12-21 RU RU2008129866/04A patent/RU2463308C2/ru active
- 2006-12-21 MX MX2008008291A patent/MX2008008291A/es active IP Right Grant
- 2006-12-21 PL PL06842187T patent/PL1976863T3/pl unknown
- 2006-12-21 NO NO20083245A patent/NO346186B1/no unknown
- 2006-12-21 KR KR1020087017946A patent/KR101413746B1/ko active Active
- 2006-12-21 WO PCT/GB2006/004890 patent/WO2007072037A1/en not_active Ceased
- 2006-12-21 US US12/158,945 patent/US8324154B2/en active Active
- 2006-12-21 EP EP11001659A patent/EP2357191A3/en not_active Withdrawn
- 2006-12-21 EP EP11001658A patent/EP2357190A3/en not_active Withdrawn
- 2006-12-21 EP EP11001654A patent/EP2348039A3/en not_active Withdrawn
- 2006-12-21 JP JP2008546630A patent/JP5559477B2/ja active Active
- 2006-12-21 EP EP06842187A patent/EP1976863B1/en active Active
- 2006-12-21 AU AU2006327973A patent/AU2006327973B2/en not_active Ceased
-
2008
- 2008-06-22 IL IL192373A patent/IL192373A/en active IP Right Grant
- 2008-07-21 ZA ZA2008/06329A patent/ZA200806329B/en unknown
-
2012
- 2012-08-22 US US13/592,246 patent/US8785375B2/en active Active
- 2012-11-16 JP JP2012252220A patent/JP6050096B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-13 CY CY20131100131T patent/CY1113770T1/el unknown
-
2014
- 2014-04-25 JP JP2014090998A patent/JP6199797B2/ja not_active Expired - Fee Related
-
2015
- 2015-08-20 IL IL240686A patent/IL240686A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013047268A5 (enExample) | ||
| CN102871996B (zh) | 一种抗菌药物组合物及其应用 | |
| JP2019108378A5 (enExample) | ||
| JP2011530534A5 (enExample) | ||
| Santoro et al. | Variation on a theme; an overview of the Tn 916/Tn 1545 family of mobile genetic elements in the oral and nasopharyngeal streptococci | |
| Gutiérrez-Martín et al. | Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade | |
| RU2012145756A (ru) | Пептиды и их применение | |
| JP2013539751A5 (enExample) | ||
| JP2013509389A5 (enExample) | ||
| JP2013542992A5 (enExample) | ||
| JP2012136541A5 (enExample) | ||
| HRP20151368T1 (hr) | C7-fluor supstituirani spojevi tetraciklina | |
| JP5756495B2 (ja) | ペプチドおよびその使用 | |
| JP2012501973A5 (enExample) | ||
| WO2010036938A3 (en) | Nanoemulsion therapeutic compositions and methods of using the same | |
| JP2016539119A5 (enExample) | ||
| JP2014532722A5 (enExample) | ||
| JP2014530220A5 (enExample) | ||
| JP2017523985A5 (enExample) | ||
| MX2010002278A (es) | Farmacos antivirales para el tratamiento de una infeccion por arenavirus. | |
| RU2018114480A (ru) | Соли и твердые формы монобактамного антибиотика | |
| JP2018500387A5 (enExample) | ||
| JP2013523718A5 (enExample) | ||
| JP2017519730A5 (enExample) | ||
| JP2012513467A5 (enExample) |